ArticleFrontiers in molecular biosciences2026
Comparison of machine learning models for hemoglobin prediction in patients undergoing maintenance hemodialysis.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-omics and spatial transcriptomics decode the ZDHHC9-driven hypoxia-immunosuppressive axis in hepatocellular carcinoma.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To estimate the next hemoglobin (Hb) levels in maintenance hemodialysis (MHD) patients, predictive models were developed using various Machine Learning (ML) algorithms. Methods: A total of 8,159 records from 2,104 MHD patients across 24 blood purification centers in Shenzhen were included. Eight ML algorithms were employed to develop prediction models: Linear Regression (LR), Least Absolute Shrinkage and Selection Operator (Lasso), Bayesian Ridge, Gradient Boosting (XGBoost), Random Forest (RF), Support Vector Machine (SVM), Multilayer Perceptron (MLP), and Long Short-Term Memory (LSTM). Subsequently, the performance of models was evaluated and compared. Results: Among all the models, the MLP performed the best performance, with an Conclusion: ML models based on demographic characteristics, dialysis records, and historical Hb data can effectively predict future Hb levels in MHD patients, which is helpful for early identification of anemia risk and timely clinical intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.